Posted 20 September 2017
By Jenifer Ehreth, MHA, PhD
This profile summarizes the reimbursement process, presents key stakeholders in France and highlights complexities to be considered early in the development process.
Share this article:
Categories: Biologics and biotechnology, Drugs, Medical Devices, Reimbursement, Features, Europe
Tags: ANSM, ACAM, CEESP, CEPS, Reimbursement, France